I

Indaptus Therapeutics
D

INDP

0.77300
USD
0.01
(1.71%)
مغلق
حجم التداول
100
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
9,286,745
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Indaptus Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.